...
...
...
| Iacono, A., Wang, T., Tadrous, M., Campbell, T., Kolla, G., Leece, P., Sproule, B., Kleinman, R.A., Besharah, J., Munro, C., Doolittle, M. & Gomes, T. 2024. 1001/jamapsychiatry.2024.2162 |
 Fentanyl, carfentanil and other fentanyl analogues in Canada’s illicit opioid supply: A cross-sectional studyRobert KleinmanDespite the increase in fentanyl-involved overdose deaths in Canada, there have been no national-level studies evaluating the… |
 High-Dose Buprenorphine Initiation: A Scoping ReviewStanley Wong, Nicholas Fabiano, Declan Webber, Robert KleinmanHigh-dose buprenorphine initiation has not been associated with reported cases of overdose or respiratory depression. However, the current literature about high-dose buprenorphine is limited by… |
https://link.springer.com/article/10.1007/s11606-024-08642-9 |
 Characteristics, Treatment Patterns and Retention with Extended-Release Subcutaneous Buprenorphine for Opioid Use Disorder: A Population-Based Cohort Study in Ontario, Canada.Drug Alcohol Depend, 254:111032.Anita Iacono, Tianru Wang, Mina Tadrous, Tonya Campbell, Gillian Kolla, Pamela Leece, Beth Sproule, Robert Kleinman…Uptake and retention for opioid agonist treatment (OAT) remains low. Novel extended-release formulations may improve OAT accessibility by reducing the frequency of healthcare visits. Our aim was to examine uptake, characteristics, treatment patterns and retention of individuals… |
| https://www.cmaj.ca/content/196/2/E53 |
| Expand | ||
|---|---|---|
| ||